Cary Street Partners Investment Advisory’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $120K | Buy |
4,941
+2,182
| +79% | +$52.9K | 0.06% | 308 |
|
|
2025
Q1 | $69.9K | Sell |
2,759
-630
| -19% | -$16K | 0.04% | 338 |
|
|
2024
Q4 | $89.9K | Sell |
3,389
-132,430
| -98% | -$3.51M | 0.06% | 267 |
|
|
2024
Q3 | $3.93M | Sell |
135,819
-4,338
| -3% | -$126K | 0.14% | 162 |
|
|
2024
Q2 | $3.92M | Sell |
140,157
-4,745
| -3% | -$133K | 0.16% | 152 |
|
|
2024
Q1 | $4.02M | Sell |
144,902
-10,076
| -7% | -$280K | 0.17% | 149 |
|
|
2023
Q4 | $4.46M | Sell |
154,978
-12,054
| -7% | -$347K | 0.21% | 133 |
|
|
2023
Q3 | $5.54M | Buy |
167,032
+22,276
| +15% | +$739K | 0.3% | 94 |
|
|
2023
Q2 | $5.31M | Buy |
144,756
+3,026
| +2% | +$111K | 0.34% | 77 |
|
|
2023
Q1 | $5.78M | Buy |
141,730
+467
| +0.3% | +$19.1K | 0.42% | 65 |
|
|
2022
Q4 | $7.24M | Sell |
141,263
-4,676
| -3% | -$240K | 0.53% | 53 |
|
|
2022
Q3 | $6.39M | Buy |
145,939
+20,184
| +16% | +$883K | 0.53% | 54 |
|
|
2022
Q2 | $6.59M | Buy |
125,755
+103,647
| +469% | +$5.43M | 0.56% | 53 |
|
|
2022
Q1 | $1.15M | Buy |
22,108
+6,936
| +46% | +$359K | 0.31% | 97 |
|
|
2021
Q4 | $896K | Buy |
15,172
+1,638
| +12% | +$96.7K | 0.25% | 103 |
|
|
2021
Q3 | $582K | Buy |
13,534
+554
| +4% | +$23.8K | 0.19% | 122 |
|
|
2021
Q2 | $508K | Buy |
12,980
+779
| +6% | +$30.5K | 0.16% | 131 |
|
|
2021
Q1 | $442K | Sell |
12,201
-59,649
| -83% | -$2.16M | 0.18% | 131 |
|
|
2020
Q4 | $2.65M | Buy |
71,850
+45,398
| +172% | +$1.67M | 0.51% | 47 |
|
|
2020
Q3 | $921K | Buy |
26,452
+15,206
| +135% | +$529K | 0.19% | 132 |
|
|
2020
Q2 | $348K | Buy |
+11,246
| New | +$348K | 0.49% | 61 |
|
|
2020
Q1 | – | Sell |
-8,137
| Closed | -$302K | – | 108 |
|
|
2019
Q4 | $302K | Buy |
+8,137
| New | +$302K | 0.33% | 81 |
|
|
2018
Q4 | $339K | Buy |
+8,194
| New | +$339K | 0.33% | 56 |
|